Literature DB >> 9445394

Cloning, differential regulation and tissue distribution of alternatively spliced isoforms of ADP-ribosylation-factor-dependent phospholipase D from rat liver.

K Katayama1, T Kodaki, Y Nagamachi, S Yamashita.   

Abstract

An alternatively spliced isoform of ADP-ribosylation-factor-dependent phospholipase D (PLD1) was previously shown to occur in rat C6 cells [Yoshimura, Nakashima, Ohguchi, Sakai, Shinoda, Sakai and Nozawa (1996) Biochem. Biophys. Res. Commun. 225, 494-499] and human HeLa cells [Hammond, Jenco, Nakashima, Cadwallader, Gu, Cook, Nozawa, Prestwich, Frohman and Morris (1997) J. Biol. Chem. 272, 3860-3868]. However, its complete sequence and the enzymological difference between the two PLD1 isoforms were unclear. Here we report the cloning, complete sequence, enzymological properties and tissue distribution of each of the two alternatively spliced PLD1 isoforms, a and b, from rat liver. The major difference between the two isoforms was the deletion of 38 amino acids in the b isoform, but otherwise the two cDNA sequences were 99.9% identical. The a-isoform sequence was 91% identical with the a form of human PLD1, and the 38-amino-acid deletion in the b form occurred at the same site as in the b form of human PLD1. Both of the rat PLD1 isoforms expressed in the fission yeast Schizosaccharomyces pombe were dependent on ADP-ribosylation factor 1 and phosphatidylinositol 4,5-bisphosphate. The a isoform was activated by RhoA in a synergistic manner with ADP-ribosylation factor 1, whereas the b isoform was less responsive to RhoA. Reverse transcription PCR showed that the b form was the predominant PLD1 isoform expressed in rat tissues. The b-form transcript occurred in various rat tissues, including lung, brain, liver, kidney, small intestine and colon, whereas the a-form transcript was only detectable in lung, heart and spleen. Both transcripts were hardly detectable in thymus, stomach, testis and muscle. Thus the two PLD1 isoforms were differently regulated and expressed in rat tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445394      PMCID: PMC1219088          DOI: 10.1042/bj3290647

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Tissue-specific distribution and subcellular distribution of phospholipase D in rat: evidence for distinct RhoA- and ADP-ribosylation factor (ARF)-regulated isoenzymes.

Authors:  J J Provost; J Fudge; S Israelit; A R Siddiqi; J H Exton
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

2.  Resolved phospholipase D activity is modulated by cytosolic factors other than Arf.

Authors:  W D Singer; H A Brown; G M Bokoch; P C Sternweis
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

3.  Phospholipase D signaling is essential for meiosis.

Authors:  K Rose; S A Rudge; M A Frohman; A J Morris; J Engebrecht
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

4.  The turning point in genome research.

Authors:  M S Boguski
Journal:  Trends Biochem Sci       Date:  1995-08       Impact factor: 13.807

5.  Differential mRNA expression of phospholipase D (PLD) isozymes during cAMP-induced differentiation in C6 glioma cells.

Authors:  S Yoshimura; S Nakashima; K Ohguchi; H Sakai; J Shinoda; N Sakai; Y Nozawa
Journal:  Biochem Biophys Res Commun       Date:  1996-08-14       Impact factor: 3.575

6.  Involvement of Ral GTPase in v-Src-induced phospholipase D activation.

Authors:  H Jiang; J Q Luo; T Urano; P Frankel; Z Lu; D A Foster; L A Feig
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

7.  Expression of mammalian protein kinase C in Schizosaccharomyces pombe: isotype-specific induction of growth arrest, vesicle formation, and endocytosis.

Authors:  N T Goode; M A Hajibagheri; G Warren; P J Parker
Journal:  Mol Biol Cell       Date:  1994-08       Impact factor: 4.138

8.  Synergistic activation of rat brain phospholipase D by ADP-ribosylation factor and rhoA p21, and its inhibition by Clostridium botulinum C3 exoenzyme.

Authors:  H Kuribara; K Tago; T Yokozeki; T Sasaki; Y Takai; N Morii; S Narumiya; T Katada; Y Kanaho
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

9.  Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family.

Authors:  S M Hammond; Y M Altshuller; T C Sung; S A Rudge; K Rose; J Engebrecht; A J Morris; M A Frohman
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

10.  Formation of phosphatidylethanol in rat brain by phospholipase D.

Authors:  L Gustavsson; C Alling
Journal:  Biochem Biophys Res Commun       Date:  1987-02-13       Impact factor: 3.575

View more
  12 in total

1.  Elevation of oleate-activated phospholipase D activity during thymic atrophy.

Authors:  Youngkyun Lee; Soo-Mee Song; Heung Soon Park; Sungyeol Kim; Eun-Hee Koh; Myung Sun Choi; Myung-Un Choi
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Phospholipase D is involved in myogenic differentiation through remodeling of actin cytoskeleton.

Authors:  Hiba Komati; Fabio Naro; Saida Mebarek; Vania De Arcangelis; Sergio Adamo; Michel Lagarde; Annie-France Prigent; Georges Némoz
Journal:  Mol Biol Cell       Date:  2004-12-22       Impact factor: 4.138

Review 3.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 4.  Phospholipase D: molecular and cell biology of a novel gene family.

Authors:  M Liscovitch; M Czarny; G Fiucci; X Tang
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 5.  Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle.

Authors:  Troy A Hornberger
Journal:  Int J Biochem Cell Biol       Date:  2011-05-19       Impact factor: 5.085

6.  The uncovering of a novel regulatory mechanism for PLD2: formation of a ternary complex with protein tyrosine phosphatase PTP1B and growth factor receptor-bound protein GRB2.

Authors:  Jeff Horn; Isabel Lopez; Mill W Miller; Julian Gomez-Cambronero
Journal:  Biochem Biophys Res Commun       Date:  2005-06-24       Impact factor: 3.575

Review 7.  Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.

Authors:  Wenjuan Su; Qin Chen; Michael A Frohman
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

8.  Nerve growth factor- and epidermal growth factor-stimulated translocation of the ADP-ribosylation factor-exchange factor GRP1 to the plasma membrane of PC12 cells requires activation of phosphatidylinositol 3-kinase and the GRP1 pleckstrin homology domain.

Authors:  K Venkateswarlu; F Gunn-Moore; P B Oatey; J M Tavaré; P J Cullen
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

9.  Mechanism of enzymatic reaction and protein-protein interactions of PLD from a 3D structural model.

Authors:  Madhu Mahankali; Gerald Alter; Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2014-10-12       Impact factor: 4.315

Review 10.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.